Authors: MORALES J DURAN C ARTIGAS G MUNOZ G FIERRO A VUKUSICH A MANALICH J BRAHM J

Citation: J. Morales et al., IMPACT OF PROPHYLACTIC MEASURES ON PREVALENCE OF ANTI HCV AND VIRAL GENOTYPES IN A DIALYSIS UNIT, Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2805-2807

Authors: GOEREE R MANALICH J GROOTENDORST P BEECROFT ML CHURCHILL DN

Citation: R. Goeree et al., COST-ANALYSIS OF DIALYSIS TREATMENTS FOR END-STAGE RENAL-DISEASE (ESRD), Clinical and investigative medicine, 18(6), 1995, pp. 455-464

Authors: ELGUETA L MANALICH J SAFFIE A

Citation: L. Elgueta et al., QUALITY-OF-LIFE ASSESSMENT IN PATIENTS OL DER THAN 60 YEARS IN CHRONIC-HEMODIALYSIS PROGRAMS, Revista Medica de Chile, 122(6), 1994, pp. 679-685